Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $920,621 (100.0% shares, 0.0% debt)

Holdings (13)

— Kinnate Biopharma Inc. 41.8%

Value ($000) $384,738 Shares 9,671,643 Est. Cost $39.78 Unrealized —

KROS Keros Therapeutics, Inc. 10.8%

Value ($000) $99,652 Shares 1,412,705 Est. Cost $30.81 Unrealized +104.5%

RLAY Relay Therapeutics, Inc. 9.7%

Value ($000) $88,913 Shares 2,139,380 Est. Cost $38.13 Unrealized +18.6%

ALXO ALX Oncology Holdings Inc. 9.1%

Value ($000) $83,917 Shares 973,514 Est. Cost $39.31 Unrealized +53.0%

NRIX Nurix Therapeutics, Inc. 8.4%

Value ($000) $77,196 Shares 2,347,804 Est. Cost $25.20 Unrealized +31.5%

KURA Kura Oncology, Inc. 6.4%

Value ($000) $59,049 Shares 1,807,982 Est. Cost $20.13 Unrealized +74.6%

OLMA Olema Pharmaceuticals, Inc. 4.3%

Value ($000) $39,331 Shares 818,030 Est. Cost $46.89 Unrealized 0.0%

CYTK Cytokinetics Incorporated 3.2%

Value ($000) $29,840 Shares 1,435,992 Est. Cost $8.72 Unrealized +109.6%

— Generation Bio Co. 2.6%

Value ($000) $24,323 Shares 857,939 Est. Cost $21.00 Unrealized —

PCVX Vaxcyte, Inc. 1.3%

Value ($000) $12,377 Shares 465,821 Est. Cost $32.16 Unrealized +15.6%

— Cymabay Therapeutics, Inc. 1.1%

Value ($000) $10,258 Shares 1,787,094 Est. Cost $3.49 Unrealized —

ACRS Aclaris Therapeutics, Inc. 0.7%

Value ($000) $6,155 Shares 951,384 Est. Cost $3.92 Unrealized +7.7%

— Therapeutics Acquisition Corp 0.5%

Value ($000) $4,872 Shares 350,000 Est. Cost $14.38 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Kinnate Biopharma Inc.	9,671,643	$384,738	41.8%	$39.78	—	COM	49705R105
KROS	Keros Therapeutics, Inc.	1,412,705	$99,652	10.8%	$30.81	+104.5%	COM	492327101
RLAY	Relay Therapeutics, Inc.	2,139,380	$88,913	9.7%	$38.13	+18.6%	COM	75943R102
ALXO	ALX Oncology Holdings Inc.	973,514	$83,917	9.1%	$39.31	+53.0%	COM	00166B105
NRIX	Nurix Therapeutics, Inc.	2,347,804	$77,196	8.4%	$25.20	+31.5%	COM	67080M103
KURA	Kura Oncology, Inc.	1,807,982	$59,049	6.4%	$20.13	+74.6%	COM	50127T109
OLMA	Olema Pharmaceuticals, Inc.	818,030	$39,331	4.3%	$46.89	0.0%	COM	68062P106
CYTK	Cytokinetics Incorporated	1,435,992	$29,840	3.2%	$8.72	+109.6%	COM	23282W605
—	Generation Bio Co.	857,939	$24,323	2.6%	$21.00	—	COM	37148K100
PCVX	Vaxcyte, Inc.	465,821	$12,377	1.3%	$32.16	+15.6%	COM	92243G108
—	Cymabay Therapeutics, Inc.	1,787,094	$10,258	1.1%	$3.49	—	COM	23257D103
ACRS	Aclaris Therapeutics, Inc.	951,384	$6,155	0.7%	$3.92	+7.7%	COM	00461U105
—	Therapeutics Acquisition Corp	350,000	$4,872	0.5%	$14.38	—	COM CL A	88339T103